BioNTech SE News
Pfizer Stock Turns Higher After Covid Sales Power Q2 Earnings Beat, Profit Guidance Boost
Pfizer held to its forecast of $54 billion in Covid related sales this year following stronger-than-expected second quarter earnings and record overall revenues.
Pfizer Stock Jumps On $3.2 Billion U.S. Covid Vaccine Sale, FDA Paxlovid Approval Filing
“As the Covid pandemic continues to evolve and be highly unpredictable, we must remain vigilant in protecting those who are at greatest risk of getting very sick from Covid," said CEO Albert Bourla.
Cramer's Mad Money Recap 5/18: Target, Walmart, Wingstop
Jim Cramer cautions that knowing when the bottom has arrived and knowing when to buy back into the market is never easy. Don't risk missing out.
New Biotech Startup Looks to Take On Pfizer, Moderna
Fighting hidden coronavirus variants is like a whack-a-mole game and this company wants to try a new approach.
Moderna Stock Surges On Q4 Earnings Beat, 2022 Covid Vaccine Sales Boost
Moderna said it now sees sales of Spikevax rising to $19 billion this year, with additional signed options of approximately $3 billion.
Pfizer Beats Q4 Earnings Forecast, Sees $54 Billion In 2022 Covid Sales; Stock Slides
Pfizer said combined sales of its Covid vaccine and treatment drugs would rise to $54 billion this year, around half of its total projected revenues.
Moderna Wins Full FDA Approval For 'Spikevax' Covid Vaccine
The U.S. Food & Drug Administration has given its full and final approval for the use of Moderna's 'Spikevax' Covid vaccine, the drugmaker said Monday.
Pfizer Could Manufacture Up to 100 Million Omicron Vaccine Doses In Spring
Pfizer is ready to provide 50 million to 100 million vaccine doses for people who are found positive with the omicron variant of the coronavirus if it is needed.
Pfizer, BioNTech to Jointly Develop Shingles Vaccine
The collaboration will be based on mRNA technology and builds on Pfizer and BioNTech's successful effort to produce a Covid vaccine.
Fourth Covid Booster Likely Needed By Fall, Moderna CEO Says
The efficacy of boosters against Covid-19 is likely to decline and people may need another shot in the fall of 2022, Moderna CEO Stephane Bancel says.
Is This Synthetic Biology Pioneer On The Right Track?
Amyris is showing progress in one key area, but it may not be enough.
'Pharma Bro' Martin Shkreli's Crypto Conversion Turns Sour
The disgraced investor and convicted felon launched a cryptocurrency last July after his release from prison.
Over 1.7 Million Fords And Lincolns Are At Risk Of Being Recalled
The National Highway Transit Safety Administration received over 50 complaints over brake hose ruptures.